Solid Support And Method Of Culturing Cells On Said Solid Support Patents (Class 435/395)
-
Patent number: 8772049Abstract: Screening assays and methods of performing such assays are provided. In certain examples, the assays and methods may be designed to determine whether or not two or more species can associate with each other. In some examples, the assays and methods may be used to determine if a known antigen binds to an unknown monoclonal antibody.Type: GrantFiled: August 6, 2013Date of Patent: July 8, 2014Assignee: President and Fellows of Harvard CollegeInventors: J. Christopher Love, Hidde L. Ploegh, Jehnna Ronan
-
Patent number: 8771720Abstract: Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and/or solubility in non-toxic solvents, are also described. The PHAs are suitable for use in in vivo applications such as in tissue coatings, stents, sutures, tubing, bone, other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses.Type: GrantFiled: July 10, 2012Date of Patent: July 8, 2014Assignee: Metabolix, Inc.Inventors: Simon F. Williams, David P. Martin, Tillman Gerngross, Daniel M. Horowitz
-
Patent number: 8765473Abstract: A basement membrane having a barrier function is formed by culturing alveolar epithelial cells or vascular endothelial cells on a fibrous collagen matrix coated with a polymer having a sugar chain that can localize a receptor that has an activity to accumulate a basement membrane component on the basal surface of the cells having an ability to form a basement membrane. A reconstructed artificial tissue is obtained by seeding and culturing desired homogeneous or heterogeneous cells on the basement membrane specimen constructed by the following process: (i) the cells having an ability to form a basement membrane adhered onto a support structure through a basement membrane are treated with a surface active agent; (ii) the lipid component of cells is lysed; (iii) the mixture of an alkaline solution and a protease inhibitor is used to lyse the protein remained on the surface of the basement membrane of the cells.Type: GrantFiled: November 15, 2006Date of Patent: July 1, 2014Assignees: Japan Science and Technology Agency, National Institute for Environmental StudiesInventor: Katsumi Mochitate
-
Patent number: 8765469Abstract: A method for preparing lymphocytes characterized in that the method comprises the step of carrying out expansion in the presence of (a) fibronectin, a fragment thereof or a mixture thereof, (b) a CD3 ligand, and (c) a CD28 ligand.Type: GrantFiled: August 10, 2006Date of Patent: July 1, 2014Assignee: Takara Bio Inc.Inventors: Takahiro Marui, Kinuko Nagamine, Nobuko Muraki, Akiko Kato, Tatsuji Enoki, Hiroaki Sagawa, Ikunoshin Kato
-
Patent number: 8765472Abstract: The present invention relates to methods and devices to obtain multicellular arrangements in stable, stationary and reproducible spatial configuration, and optionally with controlled internal cell organization, methods for preparing such devices, methods for studying the cells' shapes, the cells' architectures, the cells' mechanical equilibrium, the cell-cell interaction, the cell movement and migration, the cell differentiation, the global internal cells' organizations, the cells' polarities and division, and/or any function of cells, methods for screening compounds of interest which enhance or inhibit specific cell functions.Type: GrantFiled: October 23, 2009Date of Patent: July 1, 2014Assignee: Commissariat a l'Energie Atomique et aux Energies AlternativesInventor: Manuel Thery
-
Patent number: 8765464Abstract: The present invention provide: a novel process for culturing animal cells and a kit for culturing animal cells, in which, even if the number of cells as sampled for biopsy is extremely small, the proliferation can sufficiently be maintained so as to enable to carry out various culture and/or tests, especially anticancer agent sensitivity tests, and the contamination with bacteria can be inhibited without damaging physiological activity of cells, especially sensitivity to anticancer agents. The process for culturing animal cells, according to the present invention, comprises the step of culturing a sample containing animal cells obtained from living body tissue in order to subject the sample to further culture and/or a test, with the process being characterized in that a culture medium is used wherein the culture medium has a proliferating action and physiological activity-retaining action on the animal cells, and further has a killing action and/or multiplication-inhibition action on bacteria.Type: GrantFiled: June 22, 2007Date of Patent: July 1, 2014Assignee: Kurashiki Boseki Kabushiki KaishaInventors: Kazuhiko Minamigawa, Hisayuki Kobayashi, Toshikazu Takano
-
Publication number: 20140178343Abstract: The present disclosure provides tissue supports and methods for preparing a cartilage composition for repairing cartilage defects, which is prepared by expanding and integrating small cartilage tissue pieces derived from donor or engineered tissue. The methods and supports described herein promote cell migration and integration of neighboring tissue pieces in culture to form the cartilage composition. Methods of cartilage repair using the cartilage composition are also described.Type: ApplicationFiled: March 13, 2013Publication date: June 26, 2014Inventors: Jian Q. Yao, Hali Wang
-
Publication number: 20140178920Abstract: The invention relates to a solid support suitable for supporting endothelial cell growth which has one or more regions of microstructure incorporated onto the growing surface thereof as well as to such supports having endothelial cells attached thereto. The invention further relates to methods of culturing endothelial cells and directing tubule formation using these supports.Type: ApplicationFiled: July 30, 2012Publication date: June 26, 2014Applicant: UNIVERSITY OF ULSTERInventors: George Burke, Brian Meenan, Alan Brown
-
Patent number: 8753880Abstract: A method of enriching stem or progenitor cells that includes growing a heterogeneous cell sample comprising stem and/or progenitor cells on a first substrate that is hydrophobic and has an elastic modulus less than about 100 MPa; recovering the heterogeneous cell sample from the first substrate; growing the recovered heterogeneous cell sample on a second substrate that is hydrophilic and has an elastic modulus higher than the elastic modulus of the first substrate to produce a subpopulation of nonadherent cells and a subpopulation of adherent cells; and recovering the nonadherent cell subpopulation, which is enriched for stem and/or progenitor cells.Type: GrantFiled: July 9, 2012Date of Patent: June 17, 2014Assignee: University of RochesterInventors: Lisa DeLouise, Siddarth Chandrasekaran
-
Patent number: 8753885Abstract: Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.Type: GrantFiled: January 2, 2013Date of Patent: June 17, 2014Assignee: CorMatrix Cardiovascular, IncInventor: Robert G Matheny
-
Patent number: 8753886Abstract: Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.Type: GrantFiled: May 1, 2013Date of Patent: June 17, 2014Assignee: CorMatrix Cardiovascular, Inc.Inventor: Robert G Matheny
-
Publication number: 20140162364Abstract: A method for producing a porous calcium polyphosphate structure, which comprises the steps of mixing monocalcium phosphate (MCP) with silicic acid, and sintering the mixture at a predefined temperature or temperatures for a predefined time, after which the porous calcium polyphosphate is obtained. The method allows a porous biomaterial with a controllable porosity to be obtained, and which also has the ability to activate the platelets in a plasma rich in platelets and cause the release of growth factors from the platelets.Type: ApplicationFiled: December 11, 2013Publication date: June 12, 2014Applicant: BIOTECHNOLOGY INSTITUTE, I MAS D, S.L.Inventor: Eduardo ANITUA ALDECOA
-
Patent number: 8748180Abstract: A microfluidic device for culturing cells, termed a microscale cell culture analog (?CCA), is provided. The microfluidic device allows multiple cell or tissue types to be cultured in a physiologically relevant environment, facilitates high-throughput operation and can be used for drug discovery. The microfluidic device uses gravity-induced fluidic flow, eliminating the need for a pump and preventing formation of air bubbles. Reciprocating motion between a pair of connected reservoirs is used to effect the gravity-induced flow in microfluidic channels. Bacterial contamination is reduced and high throughput enabled by eliminating a pump. The microfluidic device integrates a pharmacokinetic-pharmacodynamic (PK-PD) model to enable PK-PD analyses on-chip. This combined in vitro/in silico system enables prediction of drug toxicity in a more realistic manner than conventional in vitro systems.Type: GrantFiled: July 29, 2010Date of Patent: June 10, 2014Assignee: Cornell UniversityInventors: Michael L. Shuler, Jong Hwan Sung
-
Patent number: 8748181Abstract: The present invention provides methods of generating and devices of patterned soft substrates, on which cells may be seeded, as well as methods of using these substrates. Devices containing these patterned soft substrates are also provided.Type: GrantFiled: May 22, 2009Date of Patent: June 10, 2014Assignee: President and Fellows of Harvard CollegeInventors: Po-Ling Kuo, Adam W. Feinberg, Kevin Kit Parker
-
Patent number: 8748142Abstract: Materials for culturing cardiovascular tissues wherein a sponge made of a bioabsorbable material is reinforced with a reinforcement made of a bioabsorbable material.Type: GrantFiled: November 10, 2009Date of Patent: June 10, 2014Assignees: Gunze Limited, Tokyo Women's Medical UniversityInventors: Shinichiro Morita, Toshiharu Shin'Oka, Yasuharu Imai
-
Publication number: 20140155904Abstract: The invention relates to a biomaterial containing calcium phosphate, in particular hydroxyapatite or a material containing hydroxyapatite, such as biphasic calcium phosphates and calcium phosphate cements, and to the use thereof for the production of an implant or for fitting a prosthesis for the purpose of bone tissue regeneration.Type: ApplicationFiled: June 21, 2013Publication date: June 5, 2014Applicants: Centre Hospitalier Universitaire de Nice, Center National de la Recherche ScientifiqueInventors: Thierry Balaguer, Nathalie Rochet, Georges Carle
-
Patent number: 8741645Abstract: The present invention provides a method for performing a biological test under conditions in which an artificially prepared cell pattern with initial position coordinates that can be determined is three-dimensionally cultured within a gelled matrix. The present invention relates to a biological test method that comprises testing a biological indicator with reference to at least one selected from the group consisting of cell proliferation, cell movement, and cell differentiation in a cell pattern substantially embedded in gel. The present invention also relates to a kit for the biological test method.Type: GrantFiled: April 22, 2011Date of Patent: June 3, 2014Assignee: Dai Nippon Printing Co., Ltd.Inventors: Hideshi Hattori, Norihiko Okochi, Masatoshi Kuroda, Masahiko Hase
-
Patent number: 8735154Abstract: A scaffold having islet cells or small islet cell clusters attached thereto in a multilayer, and a micro-mold having divots for culturing islets, wherein islet formation is influenced by the shape and dimensions of the divots are disclosed.Type: GrantFiled: April 6, 2010Date of Patent: May 27, 2014Assignee: The University of KansasInventors: Cory Berkland, Lisa A. Stehno-Bittel, Teruna Siahaan, Karthik Ramachandran
-
Patent number: 8735117Abstract: In on aspect, the invention includes a microcarrier bead having a porous three-dimensional core having (a) a polymeric porous three-dimensional body having porosity of about 15 to about 90% such that at least 99% of pores are interconnected and have diameters of at most 200 microns, (b) an outer protective layer and optionally (c) a filler. In another aspect, the invention includes a method of making an artificial scaffold wherein a scaffolding material is extruded into a coolant and thereby creating a porous material having a porosity of between 15-90% such that at least 99% of pores are interconnected and have diameters of at most 200 microns.Type: GrantFiled: September 8, 2010Date of Patent: May 27, 2014Assignee: Drexel UniversityInventors: Andrew Darling, Lauren Shor, Wei Sun, Selcuk Guceri
-
Patent number: 8735155Abstract: Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.Type: GrantFiled: September 27, 2013Date of Patent: May 27, 2014Assignee: CorMatrix Cardiovascular, Inc.Inventor: Robert G Matheny
-
Patent number: 8728807Abstract: Structures and methods for tissue engineering include a multicellular body including a plurality of living cells. A plurality of multicellular bodies can be arranged in a pattern and allowed to fuse to form an engineered tissue. The arrangement can include filler bodies including a biocompatible material that resists migration and ingrowth of cells from the multicellular bodies and that is resistant to adherence of cells to it. Three-dimensional constructs can be assembled by printing or otherwise stacking the multicellular bodies and filler bodies such that there is direct contact between adjoining multicellular bodies, suitably along a contact area that has a substantial length. The direct contact between the multicellular bodies promotes efficient and reliable fusion. The increased contact area between adjoining multicellular bodies also promotes efficient and reliable fusion.Type: GrantFiled: February 22, 2012Date of Patent: May 20, 2014Assignee: The Curators of the University of MissouriInventors: Gabor Forgacs, Francoise Suzanne Marga, Cyrille Norotte
-
Patent number: 8728464Abstract: Nanostructures such as nanowires, nanosprings, nanorods, and nanoparticles, when maintained in contact with a source of bone cells, enhance the proliferation of the bone cells and integration bone into the nanostructures. The nanostructures may or may not be coated with a metal or metal oxide coating and preferably are textured. Such coated or non-coated nanostructures may be utilized on the surface of bone implants to enhance osseointegration of the implants.Type: GrantFiled: July 19, 2011Date of Patent: May 20, 2014Assignee: University of IdahoInventor: Jamie Haas
-
Patent number: 8722404Abstract: Method for regeneration of mesenchymal tissue from mesenchymal cells on a porous sheet composed of bioabsorbable polymer material.Type: GrantFiled: February 22, 2010Date of Patent: May 13, 2014Assignees: GC Corporation, Two Cells Co. Ltd.Inventors: Toshitsugu Kawata, Kaoru Tenjo, Koichiro Tsuji, Katsuyuki Yamanaka
-
Patent number: 8722850Abstract: There is described a group of novel self-assembling peptides (SAPs), comprising biotinylated and unbiotinylated sequences, hybrid peptide-peptoid sequences, branched sequences for a total of 48 tested motifs, showing a heterogeneous ensemble of spontaneously self-assembled structures at the nano- and microscale, ranging from short tabular fibers to twisted ribbons, nanotubes and hierarchical self-assembled micrometer-long sheets. Specifically, the SAPs according to the present invention which initially spontaneous assemble, surprisingly form stable solid scaffolds upon exposure to neutral pH buffer. Further these SAPs allow adhesion, proliferation and differentiation of murine and human neural stem cells and have self-healing propensity. They also did not exert toxic effects in the central nervous system, can stop bleeding and foster nervous regeneration.Type: GrantFiled: April 19, 2011Date of Patent: May 13, 2014Assignee: Universita' Degli Studi di Milano BicoccaInventors: Angelo Luigi Vescovi, Fabrizio Gelain
-
Publication number: 20140127808Abstract: For easily seeding cells in its scaffold, a porous cell scaffold is produced by steps of filling a guiding solution with kinematic viscosity being 50 to 450% of that of a culture medium, in a whole continuous small hole structure having hole diameters of 5 to 3200 ?m and an average hole diameter of 50 to 1500 ?m, of a sheet-shaped or block-shaped scaffold having a thickness of 2 mm or more, supplying thereafter a culture medium with cells being suspended to an upper side of the scaffold, sucking the guiding solution from a lower side of the scaffold by low suction force, and entering thereby the culture medium with cells being suspended into the whole small hole structure, where a water absorber such as a filter paper is preferably used for sucking the guiding solution by low suction force.Type: ApplicationFiled: January 13, 2014Publication date: May 8, 2014Applicant: GC CORPORATIONInventors: Katsuyuki YAMANAKA, Youko SUDA, Katsushi YAMAMOTO, Yuhiro SAKAI, Tadashi KANEKO
-
Publication number: 20140127809Abstract: A perfusion device and method is provided. In one embodiment, the device includes a container having a first internal chamber configured to hold the material; a port for introducing the liquid into the chamber; a vent for releasing gas and liquid from the chamber; and a means for sealing the vent to allow a vacuum to be drawn on the first chamber The material may be biomaterial, such as a bone graft material in any form. In one embodiment, the container is a syringe that defines the internal material chamber and includes an end cap and a plunger. The vent may be formed by a venting passageway in plunger and/or cap in some embodiments. In one embodiment, the vacuum may be created by a medical syringe coupled to the container, and which in some embodiments may also be used to deliver the liquid into the container. The liquid may be bone marrow aspirate in some embodiments.Type: ApplicationFiled: January 14, 2014Publication date: May 8, 2014Applicant: DePuy Synthes Products, LLCInventors: Ed Kurek, Sean H Kerr
-
Publication number: 20140120619Abstract: A system for producing a tissue-engineered material includes a hollow member and a mechanical stimulating unit. The hollow member is adapted to be implanted in a peritoneal cavity, and is to be positioned in the peritoneal cavity in a manner that a part of the hollow member contacts an inner wall surface of the peritoneal cavity for enabling formation of a biological tissue that encapsulates the hollow member. The mechanical stimulation unit is coupled to the hollow member and configured to provide a periodic mechanical stimulus to the biological tissue by periodically causing the hollow member to expand and contract. A method for producing the aforesaid tissue-engineered material is also disclosed.Type: ApplicationFiled: August 5, 2013Publication date: May 1, 2014Applicant: NATIONAL CHENG KUNG UNIVERSITYInventors: How-Ran GUO, Chao-Lin CHEN, Jin-Jia HU, Yung-Chun LEE, Chung-Jen CHUNG
-
Patent number: 8709744Abstract: The present invention provides cellular screening substrata which can be formed in simple processing steps. The cellular screening substrata can be formed which are characterized in that plural cellular screening substances are positioned and immobilized at predetermined positions on a base by micro-droplet discharging means, and plural areas having different cellular screening functions are formed thereon.Type: GrantFiled: February 28, 2011Date of Patent: April 29, 2014Assignee: Canon Kabushiki KaishaInventors: Kenji Nishiguchi, Takeshi Miyazaki, Ryoichi Matsuda, Kohei Watanabe
-
Patent number: 8709081Abstract: A cellular scaffold that is suitable for tissue regeneration, cell culture and in vitro assays. The invention relates to a layered cell scaffold that is seeded with mesenchymal and ectodermal cells. The layered cellular scaffold comprises an inoculum of mesenchymal cells and ectodermal cells positioned between two opposing scaffolds in a sandwich configuration. The layered cell scaffold provides a functional skin equivalent that is suitable for transplantation and in vitro cell-based assays.Type: GrantFiled: October 2, 2011Date of Patent: April 29, 2014Assignee: Stemedica Cell Technologies, Inc.Inventors: Alexander Kharazi, Ludmilla Kharazi, Nikolai Tankovich
-
Patent number: 8709809Abstract: A nanofiber is formed by combining one or more natural or synthetic polymeric materials and one or more than one cross-linking agents having at least two latent reactive activatable groups. The latent reactive activatable nanofiber may be used to modify the surface of a substrate by activating at least one of the latent reactive activatable groups to bond the nanofiber to the surface by the formation of a covalent bond between the surface of the substrate and the latent reactive activatable group. Some of the remaining latent reactive activatable group(s) are left accessible on the surface of the substrate, and may be used for further surface modification of the substrate. Biologically active materials may be immobilized on the nanofiber modified surface by reacting with the latent reactive groups that are accessible on the surface of the substrate.Type: GrantFiled: June 20, 2008Date of Patent: April 29, 2014Assignee: Innovative Surface Technologies, Inc.Inventors: Jie Wen, Patrick E. Guire
-
Publication number: 20140113373Abstract: Porous soy protein-based scaffolds and methods for making the scaffolds using 3D printing techniques are provided. Also provided are tissue growth scaffolds comprising the porous soy protein-based scaffolds and methods for growing tissue on the tissue growth scaffolds. The porous soy protein-containing scaffold comprises a plurality of layers configured in a vertical stack, each layer comprising a plurality of strands comprising denatured soy proteins.Type: ApplicationFiled: October 18, 2013Publication date: April 24, 2014Inventors: Karen B. Chien, Ramille N. Shah
-
Patent number: 8703488Abstract: The invention relates to a method for culturing human embryonic stem cells (hESCs) and/or induced pluripotent stem (iPS) cells on a lectin. The invention relates also to the use of a lectin in a method for culturing human embryonic stem cells (hESCs) and/or induced pluripotent stem (iPS) celts and a culture medium composition containing a lectin attached on the culturing plates.Type: GrantFiled: July 13, 2009Date of Patent: April 22, 2014Assignees: Suomen Punainen Risti Veripalvelu, Glykos Finland OyInventors: Ulla Impola, Minna Tiittanen, Milla Mikkola, Jukka Partanen, Jari Natunen, Tero Satomaa, Juhani Saarinen
-
Patent number: 8697443Abstract: Gas permeable devices and methods are disclosed for cell culture, including cell culture devices and methods that contain medium at heights, and certain gas permeable surface area to medium volume ratios. These devices and methods allow improvements in cell culture efficiency and scale up efficiency.Type: GrantFiled: April 2, 2010Date of Patent: April 15, 2014Assignee: Wilson Wolf Manufacturing CorporationInventors: John R. Wilson, Douglas A. Page, Daniel P. Welch, Alison Robeck
-
Patent number: 8697058Abstract: The present invention relates to a method of making cytocompatible alginate gels and their use in the treatment of cardiomyopathy.Type: GrantFiled: September 20, 2012Date of Patent: April 15, 2014Assignee: Abott Cardiovascular Systems Inc.Inventors: Shubhayu Basu, Gene Michal, Florian N. Ludwig, Jinping Wan, John Stankus
-
Publication number: 20140099290Abstract: Provided herein is an endothelial scaffold comprising, consisting of, or consisting essentially of decellularized corneal stroma. In some embodiments, the scaffold has cultured endothelial cells seeded thereon. Methods of treating a patient in need of corneal endothelial transplant are also provided, including implanting the scaffold as described herein onto a cornea of the patient (e.g., by deep keratectomy).Type: ApplicationFiled: December 11, 2013Publication date: April 10, 2014Applicant: Wake Forest University Health SciencesInventors: Shay Soker, J. Koudy Williams, Patrick Laber, Margaret Greven, Keith A. Walter
-
Patent number: 8691203Abstract: The present inventions in various aspects provide elastic biodegradable polymers. In various embodiments, the polymers are formed by the reaction of a multifunctional alcohol or ether and a difunctional or higher order acid to form a pre-polymer, which is cross-linked to form the elastic biodegradable polymer. In preferred embodiments, the cross-linking is performed by functionalization of one or more OR groups on the pre-polymer backbone with vinyl, followed by photopolymerization to form the elastic biodegradable polymer composition or material. Preferably, acrylate is used to add one or more vinyls to the backbone of the pre-polymer to form an acrylated pre-polymer. In various embodiments, acrylated pre-polymers are co-polymerized with one or more acrylated co-polymers.Type: GrantFiled: March 23, 2012Date of Patent: April 8, 2014Assignee: Massachusetts Institute of TechnologyInventors: Christopher J. Bettinger, Joost P. Bruggeman, Lino Da Silva Ferreira, Jeffrey M. Karp, Robert S. Langer, Christiaan Nijst, Andreas Zumbuehl, Jason Burdick, Sonia J. Kim
-
Patent number: 8691543Abstract: The invention is directed to a device and method to prevent migration of Human Mesenchymal Stem Cells (hMSCs) from a delivery site while allowing communication between the stem cells and native cardiomyocytes. The device is characterized by scaffold pore size, fiber diameter and biomaterial selection. The invention includes a two part polyurethane scaffold that prevents migration of stem cells, allows gap junction formation through pores and is packaged for minimally invasive delivery.Type: GrantFiled: November 26, 2010Date of Patent: April 8, 2014Assignee: Worcester Polytechnic InstituteInventors: Glenn Gaudette, Matthew D. Phaneuf, Syed Ali, Brian Almeida, Helena Alfonzo, Katie Flynn
-
Publication number: 20140093962Abstract: A non-adherent cell support for use as a substrate in fluidic chambers used for cell culturing and assays. The non-adherent cell support allows for the formation of sphere cultures from single cells, which can better mimic primary tumor-like behavior in the study of cancer stem cells. The non-adherent cell support can allow for adhesive culturing and may include a hydrophobic substrate having a lower body and a raised support structure extending upwardly from an upper surface of the body. The support structure comprises one or more vertically extending support members that extend from a proximal portion at the upper surface of the body to a distal end spaced from the upper surface of the body. The support structure may be formed from a biocompatible material such as poly-2-hydroxyethyl methacrylate, polydimethylsiloxane, polymethyl methacrylate, polystyrene, or a polyethylene glycol diacrylate-based hydrogel.Type: ApplicationFiled: October 1, 2013Publication date: April 3, 2014Applicant: The Regents of the University of MichiganInventors: Patrick Neal Ingram, Euisik Yoon
-
Patent number: 8685426Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.Type: GrantFiled: April 26, 2012Date of Patent: April 1, 2014Assignee: Allergan, Inc.Inventors: Gregory H. Altman, Jingson Chen, Rebecca L. Horan, David J. Horan
-
Patent number: 8685732Abstract: The present invention relates to a biomaterial, specifically a hydrogel, formed from the extracellular matrix of the umbilical cord for its application in regenerative medicine. The invention particularly relates to a biomaterial made up of glycosaminoglycans isolated exclusively from the Wharton's jelly of the umbilical cord which can optionally contain cells, and also to the methods for the production and use thereof.Type: GrantFiled: October 10, 2008Date of Patent: April 1, 2014Assignee: Histocell, S.L.Inventors: Julio Font Perez, Maite Del Olmo Basterrechea, Maria Begona Castro Feo, Arantza Infante Martinez, Ana Isabel Alonso Varona, Teodoro Palomares Casado
-
Publication number: 20140079674Abstract: The invention provides an isolated major ampullate spidroin protein, which consists of from 150 to 420 amino acid residues and is defined by the formula REP-CT. REP is a repetitive, N-terminally derived protein fragment having from 80 to 300 amino acid residues. CT is a C-terminally derived protein fragment having from 70 to 120 amino acid residues. The invention further provides an isolated fusion protein consisting of a first protein fragment, which is a major ampullate spidroin protein, and a second protein fragment comprising a fusion partner and a cleavage agent recognition site. The first protein fragment is coupled via said cleavage agent recognition site to the fusion partner. The invention also provides a method of producing a major ampullate spidroin protein and polymers thereof.Type: ApplicationFiled: November 21, 2013Publication date: March 20, 2014Applicant: Spiber Technologies ABInventors: Jan JOHANSSON, Goran HJALM, Margareta STARK, Anna RISING, Stefan GRIP, Wilhelm ENGSTROM, My HEDHAMMAR
-
Publication number: 20140080214Abstract: A method of making a scaffold for 3 dimensional cell culture comprising the steps of conjugating a reducible disulfide bond onto a hydroxyl group at the side chain of a hydroxypropyl cellulose; forming a matrix of hydroxypropyl cellulose having the reducible disulfide bond conjugated onto the hydroxyl group such that a reducible disulfide bond exists adjacent to a double bond for crosslinking the matrix of hydroxypropyl cellulose.Type: ApplicationFiled: January 9, 2013Publication date: March 20, 2014Inventors: Bramasta Nugraha, Hanry Yu
-
Patent number: 8673638Abstract: The present invention relates to a cell culture support for culturing mesenchymal stem cells, which includes en upper surface including a plurality of wells, in which the upper surface has a root mean square roughness Rq of 100 to 280 nm and a linear density of 1.6 to 10 per 1 ?m length.Type: GrantFiled: August 5, 2011Date of Patent: March 18, 2014Assignee: Covalent Materials CorporationInventors: Fumihiko Kitagawa, Takafumi Imaizumi, Shunsuke Takei, Itsuki Yamamoto, Yasuhiko Tabata
-
Patent number: 8673640Abstract: A porous scaffold having pores for seeding cells characterized in that, in the outer peripheral face of the porous main body having the pores for seeding cells, a porous membrane having pores smaller than the cells is located. Thus, it is possible to provide a porous scaffold whereby the cells can be seeded at a high efficiency while preventing cell leakage and, moreover, even cells having little adhesiveness can be adhered.Type: GrantFiled: September 20, 2006Date of Patent: March 18, 2014Assignee: National Institute for Materials ScienceInventors: Guoping Chen, Tetsuya Tateishi, Junzo Tanaka
-
Patent number: 8673635Abstract: Isolated liver progenitor stem cells and cell populations of isolated liver progenitor stem cells are disclosed. The progenitor stem cells originate from adult liver, especially human adult liver. The isolated progenitor stem cells have uses in medicine, hepatology, inborn errors of liver metabolism transplantation, infectious diseases and liver failure. Methods of isolating these cells and their culture is described. The isolated cells are characterized before and after differentiation. Their use for transplantation and as animal models of human disease, toxicology and pharmacology is disclosed.Type: GrantFiled: December 14, 2006Date of Patent: March 18, 2014Assignee: Universite Catholique de LouvainInventors: Etienne Sokal, Mustapha Najimi
-
Publication number: 20140074253Abstract: The present invention generally relates to nanoscale wires and tissue engineering. In various embodiments, cell scaffolds for growing cells or tissues can be formed that include nanoscale wires that can be connected to electronic circuits extending externally of the cell scaffold. The nanoscale wires may form an integral part of cells or tissues grown from the cell scaffold, and can even be determined or controlled, e.g., using various electronic circuits. This approach allows for the creation of fundamentally new types of functionalized cells and tissues, due to the high degree of electronic control offered by the nanoscale wires and electronic circuits. Accordingly, such cell scaffolds can be used to grow cells or tissues which can be determined and/or controlled at very high resolutions, due to the presence of the nanoscale wires, and such cell scaffolds will find use in a wide variety of novel applications, including applications in tissue engineering, prosthetics, pacemakers, implants, or the like.Type: ApplicationFiled: September 4, 2013Publication date: March 13, 2014Applicants: President and Fellows of Harvard College, Children's Medical Center Corporation, Massachusetts Institute of TechnologyInventors: Charles M. Lieber, Jia Liu, Bozhi Tian, Tal Dvir, Robert S. Langer, Daniel S. Kohane
-
Patent number: 8669107Abstract: Methods can prepare tissue engineering scaffolds that include a plurality of biocompatible microspheres linked together to form a three-dimensional matrix. The matrix can include a plurality of pores for growing cells. The biocompatible microspheres can include first and second sets of microspheres. The first set of microspheres can have a first characteristic, and a first predetermined spatial distribution with respect to the three-dimensional matrix. The second set of microspheres can have a second characteristic that is different from the first characteristic, and a second predetermined spatial distribution that is different from the first predetermined spatial distribution with respect to the three-dimensional matrix.Type: GrantFiled: August 21, 2012Date of Patent: March 11, 2014Assignee: The University of KansasInventors: Michael Detamore, Milind Singh, Aaron M. Scurto, Cory Berkland
-
Publication number: 20140066387Abstract: The present invention concerns the field of functionalized self-assembling peptides suitable for obtaining hydrogels for use in a wide range of applications in the biomedical field, such as for the development of biomaterials for regenerative medicine and basic science research.Type: ApplicationFiled: March 14, 2012Publication date: March 6, 2014Applicant: NANOMED3D S.R.L.Inventors: Fabrizio Gelain, Angelo Luigi Vescovi
-
Patent number: 8663988Abstract: The present invention relates to collagen hydrogels. Particularly, the invention relates to hydrogels comprising a telopeptide collagen (“telo-collagen”) and an atelopeptide collagen (“atelo-collagen”); hydrogels comprising collagen and chitosan; methods of making the hydrogels; methods of reducing gelation of a hydrogel mixture at room temperature; methods of reducing compaction of cells; and methods of culturing cells on such hydrogels.Type: GrantFiled: December 9, 2011Date of Patent: March 4, 2014Assignee: MedTrain Technologies, LLCInventors: Albert J. Banes, Mari Tsuzaki, Jie Qi
-
Publication number: 20140051168Abstract: Described herein is a three-dimensional cell culture scaffold composition comprising an absorbent rigid (AR) component, and in some embodiments, further comprises a gel component. The absorbent rigid component preferably comprises a glass fiber material. It is a surprising finding of the present invention that an AR component having a void volume of between approximately 70% and 95% results in a three-dimensional cell culture composition that allows for robust, high-throughput screening and high-content screening accessible tissue models with preserved cell morphology, heterogeneity of cell types and cell populations, extracellular matrix constituents, functional cell-cell and cell-extracellular matrix interactions and signaling with sufficient specificities to tissue physiology and pathology.Type: ApplicationFiled: August 8, 2013Publication date: February 20, 2014Inventor: Jelena Vukasinovic